T is parenterally employed as a safe abortifacient in dose of 1.2 mg for woman of mid pregnancy and in combination with other medicines for early pregnancy. It is also effective in treating hydatidiform moles, ectopic pregnancy as well as choriocarcinoma.
HISTORY
Tian Hua Fen (THF) is a Chinese medicine prepared from the root tuber of the perennial plant Trichosanthes kirilowii Maxim (Cucurbitaseae). As early as in East Han Dynasty (at the beginning of the 3rd century), the famous physician Zhang Zhong-Jing had mentioned THF as traditional herbal medicine in his classical book "Synopsis of Prescriptions of the Golden Chamber". Later in Tang Dynasty (682 A. D.), the distinguished physician Sun Si-Miao wrote for the first time the successful application of THF to reset menstruation in obstetrical and gynecological cases in his famous medical book "Supplement to Prescriptions Worth a Thousand Gold". In "The Peaceful Holy Benevolent Prescriptions" compiled by Wang Huai-Yin in Song Dynasty (978-992), THF was recommended in a recipe "Gui Xin Scattered Prescriptions" for inducing abortion. In the late Ming Dynasty (1590) the great naturalist and physician Li Shi-Zhen had in his book "Compendium of Materia Medica" a very comprehensive and scientific compilation of the indication, and pharmacological properties of THF as an effective drug for "resetting menstruation" and "treating the detention of the after-birth".
In the past two to three decades, the Chinese practitioners and clinical doctors in cooperation with pharmacologists, biologists and chemists of research institutes and pharmaceutical works had screened the composite THF prescriptions of seven or eight ingredients for inducing abortion down to two and finally to one principal ingredient THF alone (Table 1 ). In the composite prescription, the so-called Tian Ya San was composed of only two ingredients, of which the most important ingredient was THF, and the other ingredient, Ya-Zao, i.e., Gedditsia sinensis Lam. The latter acted only as a surfactant, and was proved to be the main toxic factor responsible for the necrosis of the tissue at the site of the external application and pyrogenic side action. Further studies on the isolation and purification of the active abortifacient factor led to the crystallization of the active protein trichosanthin (T) ( Table 1) . 
CHEMISTRY
The root tubers are freshly collected, cut into pieces and pressed to obtain their juice. The juice is fractionally precipitated with acetone and purified by crystallization from barbiturate buffer (ref. 1). The yield of crystallized product was about 0.05% (on fresh root basis). The pure crystal is free from sugar and phosphate groups and homogeneous on agarose plate, polyacrylamide gel, SDS-polyacrylamide, gel-immuno eletrophoresis and gelpermeation and also by N-terminal amino acid determination. The active protein is named trichosanthin (T).
T is a basic protein of p1 9.4. Its molecular weight as determined by SDSpolyacrylamide gel electrophoresis is 24,000. It consists of one residue each of histidine and tryptophane but no cysteine or cystine (ref. [1] [2] [3] [4] . There are 4 methionine residues. The amino acid composition of trichosanthin is shown in Table 2 .
The N-terminal amino acid is Asp as identified by chemical methods, and the C-terminal determined by carboxypeptidase A (CPA), hydrazinolysis and 
H-Val
Hse-OH + H-Ala-OH Cyanogen bromide degradation of trichosanthin and N-succinyl-trichosanthin Both T and ST have been subjected to cyanogen bromide degradation. The degradation products from ST (ST-CNBr) were separated on Sephadex G-75 into six fractions (Peak 1-VI) (ref.
3), and, in addition, a fraction of free alanine. The N-terminal residues of Peaks III, V and VI were identified to be Val, Arg and Gly respectively. These fragments were later proved to be CB4, CB3 and CB2. The degradation produts from T (T-CNBr could also be separated into six fractions (Peaks 1-VI) (ref. 4) on Sephacryl S200 column. The eluate of Peak I was fractionally collected and the first few fractions contained the unreacted T which was cut off. The remaining fractions were rechromatographed to remove any contaminating materials. The pure peptide fragment thus isolated was identified to be the N-terminal fragment of T-CNBr, i.e., CB1. The eluate of Peak III was also fractionally collected. The first collected fractions were identified to consist of the C-terminal fragment of T, i.e., CB4. The Peak II gave mixed peptide fragments occurring in adjacent Peaks I and III. Peak IV consisted of degradation fragements occurring in Peaks III and V. Peak V was found to contain CB3, and Peak VI, CB2.
Only Peaks III, V and VI of ST-CNBr-dagradation and part of Peaks I, III and V of T-CNBr degradation were used for sequencing.
The amino acid compositions of CB1, CB2, CB3 and CB4 were shown in Table 4 . Table 4 Amino acid compositions of T-CNBr fragments Enzymic degradations of T and its fragments MT has been hydrolyzed by trypsin, SV8-protease, ot-chymotrypsin and thermolysin separately or successively, and ST, by o-chymotrypsin. The tryptic digestion mixture had only limited solubility in acidic solution.
The acid-soluble portion gave a finger print of 13 spots on two dimensional cellulose electrophoresis-chromatography and could also be separated on HPLC into corresponding peaks. All of these spots have been sequenced. The spots 1 and 2 were found to be C-terminal fragments of trichosanthin H-Asn-AsnMet-Ala-OH and H-Asn-Asn-Met-OH. The acid-insoluble portion of the tryptic digests dissolved in TMK-buffer and 8M urea was separated on Sephadex G-75 column into four fractions (TIG 1-4). TIG1 was determined to be intact MT. TIG2 was further subjected to SV8-proteolytic and thermolytic digestions separately. The demaleyl-TIG2 was digested by trypsin. The digested produts were then separated by HPLC. All the isolated peptide fragments have been sequenced.
Sequencing
The direct sequencing of the N-terminal segment of the whole T molecule by Edman-Begg process using automatic sequencer (Beckman 890C) gave 38 a.a. residues (T 1-38). The C-terminal sequence of T was determined by subjecting MT to the action of CPA with the aid of computer simulation to be H-Asn-Asn-Met-OH in accompany with H-Asn-Asn-Met-Ala-OH (ref. 5). On further subjection to CPB action followed by CPY with the application of kinetic analysis of the a.a. liberation, a total of 9 a.a. residues of the C-terminal sequence were determined which has been verified by other ways (vide infra).
Most of the informations about T sequence was obtained by sequencing the peptide fragments of cyanogen bromide cleavage and enzymic degradations of T, MT and ST.
CB1 (Peak I) sequence
The sequence of N-terminal segment of CB1 (Peak I) was shown to be identical with that of T. Further information beyond Tl-38 was provided by sequencing the peptide fragments obtained by tryptic, peptic and thermolytic digestions of CB1. The sequences of these fragments overlapped each other. The N-terminal sequence of CB1 was thus extended from Tl-38 to T1-76 by the sequences (T39-46 and T47-73) of two more tryptic fragments and by the C-terminal sequence of CB1 (T73-79) determined by CPA to Tl-79. The sequences of the above segments were joined together by the overlapping sequences of two peptic fragments (T32-39 and T38-50) and the N-termial sequence (T61-76) of a thermolytic fragment. The complete sequence of CB1 is shown to consist of 79 a.a. residues (Fig. 2) . The only His residue was found at the position T5l of this fragment. 
Pro-Leu-I le-Arg-Ser-Ser-Leu-Pro-G ly-Ser-G ln-Arg-Tyr-Ala-I le-I le-H is-
r-r - The peptide fragment isolated from Peak V of T-CNBr or ST-CNBr with Arg as its N-terminus was directly sequenced from N-terminal as well as from C-terminal. Besides, it was first subjected to the separate digestions by trypsin, -chymotrypsin and SV8-protease. The various peptide fragments from these digestions were separated and also sequenced. The results were as follows:
The direct sequencing from the N-terminal was carried out up to 25 a.a. residues (T108-132). The sequence was extended by overlapping in succession by the 23 a.a. sequence (T130-152) of a tryptic digest fragment, the 14 a.a. sequence (T142-155) of a SV8-proteolytic fragment, the 10 a.a. sequence (Tl48-l57) of an -chymotryptic fragment and the 7 a.a. C-terminal sequence (Tl53-159) of Peak V. The complete sequence (T108-159) of Peak V is composed of 52 a.a. residues (Fig. 4) .
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---Hse-OH The linking between CB1 and CB2-CB3 was established by the finding of the key sequence (T78-82) of the 5 a.a. residues (H-Ile-Met-Gly-Tyr-Arg-OH) of the N-terminal sequence of an -chymotryptic fragment of ST which overlaps the C-terminal sequence (T78-79) of CB1 and the N-terminal sequence (T80-82) of CB2. The full sequence of CB1-CB2-CB3 is now extended to 159 a.a. residues (Tl-l59).
CB4 (Peak III) sequence
What was left not dealt with is Peak III, i.e., CB4. The characteristics of CB4 are that: (1) it consists of a tryptophane residue; (2)it has Val as N-terminus; (3) its C-terminal sequence should be the same as that of T except that the Met residue of T has been changed into homoserine in CB4;
and (4) according to amino acid analysis CB4 should be composed of about 75 amino acid residues.
The sequence of CB4 except that of the C-terminal segment was determined by the following ways: (1) directly sequencing its N-terminal segment, and (2) sequencing the peptide fragments obtained from tryptic and SV8-proteolytic digestions. The results were as follows:
On automatic sequencer, 24 a.a. residues of the N-terminal sequence (Tl60-183) of CB4 were determined, which were to the most part in common with the segment sequences (Tl60-l70 and Tl73-l8l) of two tryptic digest fragments of CB4 and overlapped by the N-terminal sequence (T182-196) of a 15 a.a. segment of the above-mentioned TIG2 fragment. Thereby the N-terminal sequence (Tl60-l96) was extended to 37 a.a. residues. On alignment of this resulting segment sequence with the N-terminal sequence (T185-20l) of 17 a.a. residues of another tryptic fragment of CB4, the N-terminal sequence (T160-201) of CB4 was extended to 42 a.a. residues, except that the 41st residue (T200) was not identified at that time.
As mentioned above the C-terminal segment sequence of MT has been sequenced to 9(8) a.a. from the terminal Ala (Met). On aligment of this segment sequence with the sequence (T219-231) of 13 a.a. residues of a SV8-proteolytic fragment and that (T206-222) of 17 a.a. residues of a third tryptic fragment of CB4 in succession, the sequence (T206-231) of the C-terminal of CB4 was extended from C-toward N-terminal to 26 a.a. residues with 6 and 4 a.a. residues in overlapping respectively. Now 69 out of 75 a.a. residues of CB4 have been accounted for, but the bridging sequence between the N-and C-terminals is still missing, and tryptophane residue should also be looked for.
Recently Trp residue has been located by subjecting TIG2 fragment to the cleavage by BNPS-skatole method. TIG2 was thereby splitted into two new fragments, the N-fragment (with the attached degraded tryptophane residue at its C-terminus) and the new C-fragment (with Leu at the N-terminus) (ref. sequence H-Ser-Leu-Trp-Leu-Ala--Leu-Ser-Lys--OH together with the sequence (Tl97-207) of SV8-proteolytic fragment of CB4 also serve to bridge the Nand C-terminal sequences of CB4. Therefore, there are 74 a.a. residues in the complete CB4 sequence (Tl60-233) (Fig. 5) .
Recent findings of the sequence of a pentadecapeptide fregment isolated from o(-chymotryptic-tryptic digestion product of ST shows that it is identical with the a.a. sequence of trichosanthin seqment Tl48-162 and so overlaps the C-terminal segment of CB3 (Tl48-l59) and N-terminal segment of CB4 (Tl60-l62).
The primary structure of trichosanthin
In the preceding communication (ref. 4) we have proposed the main amino acid sequence of the principal primary structure of T. Since then the missing tryptophane residue has been located, and the missing amino acid sequence in CB1 has been found, and corrections have been made for some a.a. residues in the sequences of CB1, CB3 and CB4 (See Table 5 ). The T molecule is then composed of 234 (233) On the basis of the above results the complete primary structure of trichosanthin is proposed as follows ( -c-chymotryptic fragment 5V8-proteolytic fragment CPA sequencing -CPY sequencing Table 5 Corrections for the previously proposed sequence of the principal primary structure of trichosanthin The result from the preliminary study on the laser Raman spectrum of crystal of T in the powder form shows clearly the absorption bands of Phe, Trp, Tyr and the two amide groups (amides I and III) (ref. 14). The amide I and amide III bands are characteritic of ft-pleated sheets and random structures. But the absorption band related to the random structure is very week.
CLINICAL APPLICATIONS
Trichosanthin used externally or parenteraliy in a single dose of 1.2 mg is able to induce abortion of a mid-gestation woman within 4-7 days without significant side reaction (ref. 15 ). In combination with reserpine and testosterone propionate, T is also effective in the termination of early pregnancy within 5-10 weeks (ref. 16 ).
In addition, T has been reported to have been used successfully in treating benign and malignant hydatidiform moles and ectopic pregnancy and also to be hopeful in curing choriocarcinoma cases. 
